Amino propynyl benzoic acid building block in rigid spacers of divalent ligands binding to the syk SH2 domains with equally high affinity as the natural ligand
摘要:
The construction of rigid spacers composed of amino propynyl benzoic acid building blocks is described. These spacers were used to link two phosphopeptide ligand sites towards obtaining divalent ligands with a high affinity for Syk tandem SH2 domains, which are important in signal transduction. The spacer containing two of those rigid building blocks led to a ligand which was as active as the natural ligand, indicating that this building block can be used in the design and synthesis of high affinity divalent constructs that can successfully interfere with crucial protein-protein interactions. (C) 2003 Elsevier Science Ltd. All rights reserved.
为在胶束水相反应条件下以高周转率实现可持续的无铜Sonogashira交叉偶联,开发了一种可靠且通用的方案。通过使用市售的催化剂CataCXium A Pd G3和THF作为助溶剂,各种炔烃底物可以与多种芳基卤化物有效地交叉偶联,从而提高了收率并降低了催化剂的负载量。对反应参数进行了优化,以使该过程操作简单,可靠且可扩展。该方法可通过胶束水溶液反应条件获得二卤代底物的烷基化芳烃,杂环化合物和单官能化产物,并具有提高的选择性。
Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds
申请人:Aventis Pharmaceuticals Inc.
公开号:US06541505B1
公开(公告)日:2003-04-01
This invention is directed to an (aminoiminomethyl or aminomethyl)benzoheteroaryl compound of formula I which is useful for inhibiting the activity of Factor Xa by combining said compound with a composition containing Factor Xa. The present invention is also directed to compositions containing compounds of the formula I, methods for their preparation, their use, such as in inhibiting the formation of thrombin or for treating a patient suffering from, or subject to, a disease state associated with a physiologically detrimental excess amount of thrombin.
SUBSTITUTED (AMINOIMINOMETHYL OR AMINOMETHYL)BENZOHETEROARYL COMPOUNDS AS FACTOR XA INHIBITORS
申请人:Aventis Pharmaceuticals Products Inc.
公开号:EP1140901A2
公开(公告)日:2001-10-10
US6541505B1
申请人:——
公开号:US6541505B1
公开(公告)日:2003-04-01
[EN] SUBSTITUTED (AMINOIMINOMETHYL OR AMINOMETHYL)BENZOHETEROARYL COMPOUNDS<br/>[FR] COMPOSES (AMINOIMINOMETHYL OU AMINOMETHYL)BENZOHETEROARYLE SUBSTITUES
申请人:AVENTIS PHARM PROD INC
公开号:WO2000039087A2
公开(公告)日:2000-07-06
This invention is directed to an (aminoiminomethyl or aminomethyl)benzoheteroaryl compound of formula (I): wherein X is O, S or NR1 which is useful for inhibiting the activity of Factor Xa by combining said compound with a composition containing Factor Xa. The present invention is also directed to compositions containing compounds of formula (I), methods for their preparation, their use, such as in inhibiting the formation of thrombin or for treating a patient suffering from, or subject to, a disease state associated with a physiologically detrimental excess amount of thrombin.
A General Protocol for Robust<i>Sonogashira</i>Reactions in Micellar Medium
A robust and general protocol for a sustainable copper‐free Sonogashira cross coupling under micellar aqueous reaction conditions with high turnover was developed. By using the commercially available catalyst CataCXium A Pd G3 and THF as co‐solvent, various alkyne substrates were efficiently cross‐coupled with a broad range of aryl halides, providing improved yields and low catalyst loadings. The reaction
为在胶束水相反应条件下以高周转率实现可持续的无铜Sonogashira交叉偶联,开发了一种可靠且通用的方案。通过使用市售的催化剂CataCXium A Pd G3和THF作为助溶剂,各种炔烃底物可以与多种芳基卤化物有效地交叉偶联,从而提高了收率并降低了催化剂的负载量。对反应参数进行了优化,以使该过程操作简单,可靠且可扩展。该方法可通过胶束水溶液反应条件获得二卤代底物的烷基化芳烃,杂环化合物和单官能化产物,并具有提高的选择性。